NUVAXOVID™️ COVID-19 Vaccine (Recombinant protein, Adjuvanted) - Canada - European Medical Journal

NUVAXOVID™️ COVID-19 Vaccine (Recombinant protein, Adjuvanted) – Canada

Learn about the clinical efficacy and safety data for Nuvaxovid™️ COVID-19 Vaccine (Recombinant protein, Adjuvanted), a protein subunit vaccine authorized for use in Canada. The video can be viewed at your convenience.

This content is supported by Novavax, Inc.

 

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?